Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 340

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 340
---
 to common stockholders (in thousands, except share and per share
data):

|                                                                                |     | Three Months 
 Ended        
 June 30,     
 2025         |           |   |     | Three Months 
 Ended        
 June 30,     
 2024         |           |   |
|:-------------------------------------------------------------------------------|:----|:-------------|----------:|:--|:----|:-------------|----------:|:--|
| Numerator:                                                                     |     |              |           |   |     |              |           |   |
| Net loss                                                                       |     | $            |    (2,348 | ) |     | $            |    (2,071 | ) |
| Denominator:                                                                   |     |              |           |   |     |              |           |   |
| Weighted average shares used to computing basic and diluted net loss per share |     |              | 5,604,651 |   |     |              | 5,601,651 |   |
| Net loss per share attributable to common stockholders – basic and diluted:    |     | $            |     (0.42 | ) |     | $            |     (0.37 | ) |

<div align='center'>F-49

PROFUSA, INC. AND SUBSIDIARY
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)</div>

Note 11 — Net Loss per Share Attributable to Common Stockholders (cont.)

The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:

|                                  |     | Three months ended 
           June 30, |            |    |     |      |            |    |
|                                  |     |               2025 |            |    |     | 2024 |            |    |
| Convertible preferred stock      |     |                    | 17,863,934 |    |     |      | 17,863,934 |    |
| Convertible notes payable(1)     |     |                    | 42,430,263 |    |     |      | 25,721,548 |    |
| Convertible loans                |     |                    |          — | -2 |     |      |          — | -2 |
| Options to purchase common stock |     |                    |